(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYB5B mRNA] CTD PMID:31150632 1,2-dimethylhydrazine multiple interactions ISO Cyb5b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CYB5B mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Cyb5b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYB5B mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO Cyb5b (Mus musculus) 6480464 Estradiol results in decreased expression of CYB5B mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of CYB5B mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyb5b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYB5B mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyb5b (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYB5B gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyb5b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYB5B mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYB5B mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyb5b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYB5B mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of CYB5B mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression ISO Cyb5b (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CYB5B mRNA CTD PMID:20188158 3-methylcholanthrene multiple interactions ISO CYB5B (Homo sapiens) 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to CYB5B promoter] CTD PMID:20348232 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYB5B mRNA CTD PMID:31881176 acrolein multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CYB5B mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CYB5B mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CYB5B mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO Cyb5b (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of CYB5B mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO CYB5B (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CYB5B gene CTD PMID:27153756 alpha-pinene multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CYB5B mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CYB5B mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYB5B mRNA CTD PMID:16483693 atrazine decreases expression ISO CYB5B (Homo sapiens) 6480464 Atrazine results in decreased expression of CYB5B mRNA CTD PMID:22378314 benzamidoxime multiple interactions ISO CYB5B (Homo sapiens) 6480464 [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of benzamidoxime and [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of benzamidoxime CTD PMID:22924387 benzo[a]pyrene affects methylation ISO CYB5B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CYB5B promoter CTD PMID:27901495 beta-naphthoflavone decreases expression ISO Cyb5b (Mus musculus) 6480464 beta-Naphthoflavone results in decreased expression of CYB5B mRNA CTD PMID:22234961 beta-naphthoflavone multiple interactions ISO Cyb5b (Mus musculus) 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYB5B mRNA] CTD PMID:22234961 bis(2-ethylhexyl) phthalate increases expression ISO Cyb5b (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CYB5B mRNA CTD PMID:19850644 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of CYB5B mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYB5B mRNA CTD PMID:34947998 bisphenol A affects expression ISO CYB5B (Homo sapiens) 6480464 bisphenol A affects the expression of CYB5B mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYB5B mRNA CTD PMID:25181051 cadmium atom multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYB5B mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYB5B mRNA CTD PMID:35301059 caffeine affects phosphorylation ISO CYB5B (Homo sapiens) 6480464 Caffeine affects the phosphorylation of CYB5B protein CTD PMID:35688186 carbamazepine affects expression ISO CYB5B (Homo sapiens) 6480464 Carbamazepine affects the expression of CYB5B mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Cyb5b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO Cyb5b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin increases expression ISO CYB5B (Homo sapiens) 6480464 chloropicrin results in increased expression of CYB5B mRNA CTD PMID:26352163 cisplatin increases expression ISO CYB5B (Homo sapiens) 6480464 Cisplatin results in increased expression of CYB5B mRNA CTD PMID:27594783 clofibrate multiple interactions ISO Cyb5b (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYB5B mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYB5B mRNA] CTD PMID:17585979 clozapine increases expression EXP 6480464 Clozapine results in increased expression of CYB5B mRNA CTD PMID:19441803 cobalt dichloride decreases expression ISO CYB5B (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CYB5B mRNA CTD PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYB5B mRNA CTD PMID:24386269 copper atom multiple interactions ISO CYB5B (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of CYB5B mRNA CTD PMID:20971185 copper(0) multiple interactions ISO CYB5B (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of CYB5B mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO CYB5B (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CYB5B mRNA CTD PMID:19549813 coumestrol increases expression ISO CYB5B (Homo sapiens) 6480464 Coumestrol results in increased expression of CYB5B mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO Cyb5b (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CYB5B mRNA CTD PMID:29279043 cyclosporin A increases expression ISO Cyb5b (Mus musculus) 6480464 Cyclosporine results in increased expression of CYB5B mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO CYB5B (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYB5B mRNA CTD PMID:20106945 and PMID:25562108 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CYB5B mRNA CTD PMID:21266533 dicrotophos decreases expression ISO CYB5B (Homo sapiens) 6480464 dicrotophos results in decreased expression of CYB5B mRNA CTD PMID:28302478 diquat increases expression ISO Cyb5b (Mus musculus) 6480464 Diquat results in increased expression of CYB5B protein CTD PMID:36851058 diuron decreases expression ISO CYB5B (Homo sapiens) 6480464 Diuron results in decreased expression of CYB5B mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO CYB5B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYB5B mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CYB5B protein CTD PMID:23301498 epoxiconazole decreases expression ISO Cyb5b (Mus musculus) 6480464 epoxiconazole results in decreased expression of CYB5B mRNA CTD PMID:35436446 ethanol multiple interactions ISO Cyb5b (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of CYB5B mRNA CTD PMID:30319688 ethanol affects expression ISO Cyb5b (Mus musculus) 6480464 Ethanol affects the expression of CYB5B mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO CYB5B (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of CYB5B mRNA CTD PMID:23649840 folic acid multiple interactions ISO Cyb5b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CYB5B mRNA CTD PMID:22206623 formaldehyde decreases expression ISO CYB5B (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CYB5B mRNA CTD PMID:23649840 fumonisin B1 decreases expression ISO Cyb5b (Mus musculus) 6480464 fumonisin B1 results in decreased expression of CYB5B mRNA CTD PMID:16221962 hydrogen peroxide affects expression ISO CYB5B (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of CYB5B mRNA CTD PMID:20044591 inulin multiple interactions ISO Cyb5b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYB5B mRNA CTD PMID:36331819 ivermectin decreases expression ISO CYB5B (Homo sapiens) 6480464 Ivermectin results in decreased expression of CYB5B protein CTD PMID:32959892 lead diacetate increases expression ISO Cyb5b (Mus musculus) 6480464 lead acetate results in increased expression of CYB5B mRNA CTD PMID:21829687 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CYB5B mRNA CTD PMID:19149911 methyl methanesulfonate decreases expression ISO CYB5B (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of CYB5B mRNA CTD PMID:23649840 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of CYB5B mRNA CTD PMID:28349193 methylmercury chloride decreases expression ISO CYB5B (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of CYB5B mRNA CTD PMID:28001369 miconazole increases expression ISO Cyb5b (Mus musculus) 6480464 Miconazole results in increased expression of CYB5B mRNA CTD PMID:27462272 monosodium L-glutamate multiple interactions ISO Cyb5b (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYB5B mRNA CTD PMID:19001666 N(4)-hydroxycytidine multiple interactions ISO CYB5B (Homo sapiens) 6480464 [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine and [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine CTD PMID:22924387 N-Nitrosodi-n-butylamine multiple interactions ISO CYB5B (Homo sapiens) 6480464 [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to dibutylnitrosamine CTD PMID:11733072 N-Nitrosodi-n-propylamine multiple interactions ISO CYB5B (Homo sapiens) 6480464 [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine CTD PMID:11733072 N-nitrosodiethylamine multiple interactions ISO CYB5B (Homo sapiens) 6480464 [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Diethylnitrosamine CTD PMID:11733072 N-nitrosodimethylamine multiple interactions ISO CYB5B (Homo sapiens) 6480464 [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Dimethylnitrosamine CTD PMID:11733072 NAD zwitterion multiple interactions ISO CYB5B (Homo sapiens) 6480464 [MTARC1 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine and [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine CTD PMID:25170804 NAD(+) multiple interactions ISO CYB5B (Homo sapiens) 6480464 [MTARC1 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine and [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine CTD PMID:25170804 nickel atom decreases expression ISO CYB5B (Homo sapiens) 6480464 Nickel results in decreased expression of CYB5B mRNA CTD PMID:23195993 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CYB5B mRNA CTD PMID:24136188 ozone multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CYB5B mRNA more ... CTD PMID:32699268 and PMID:35430440 paracetamol multiple interactions ISO Cyb5b (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYB5B mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYB5B mRNA] CTD PMID:17585979 paracetamol decreases expression ISO CYB5B (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYB5B mRNA CTD PMID:21420995 and PMID:25704631 paracetamol affects expression ISO Cyb5b (Mus musculus) 6480464 Acetaminophen affects the expression of CYB5B mRNA CTD PMID:17562736 perfluorohexanesulfonic acid decreases expression ISO Cyb5b (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of CYB5B mRNA CTD PMID:37995155 perfluorononanoic acid decreases expression ISO CYB5B (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYB5B mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression ISO CYB5B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYB5B mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid multiple interactions ISO Cyb5b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYB5B mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO CYB5B (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of CYB5B mRNA and perfluorooctanoic acid results in decreased expression of CYB5B protein CTD PMID:25812627 and PMID:26879310 phenethyl isothiocyanate affects binding ISO CYB5B (Homo sapiens) 6480464 CYB5B protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYB5B mRNA CTD PMID:19162173 pirinixic acid increases expression ISO Cyb5b (Mus musculus) 6480464 pirinixic acid results in increased expression of CYB5B mRNA CTD PMID:15302862 and PMID:18301758 piroxicam decreases expression ISO CYB5B (Homo sapiens) 6480464 Piroxicam results in decreased expression of CYB5B mRNA CTD PMID:21858171 potassium dichromate increases expression ISO CYB5B (Homo sapiens) 6480464 Potassium Dichromate results in increased expression of CYB5B protein CTD PMID:23718831 progesterone increases expression ISO CYB5B (Homo sapiens) 6480464 Progesterone results in increased expression of CYB5B mRNA CTD PMID:18070364 resveratrol multiple interactions ISO CYB5B (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CYB5B mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO CYB5B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYB5B mRNA CTD PMID:27188386 sodium fluoride decreases expression ISO Cyb5b (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of CYB5B protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of CYB5B mRNA CTD PMID:19281266 sulfamethoxazole hydroxylamine multiple interactions ISO CYB5B (Homo sapiens) 6480464 [MTARC1 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine and [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine CTD PMID:25170804 sulindac sulfide decreases expression ISO CYB5B (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of CYB5B mRNA CTD PMID:12734198 temozolomide decreases expression ISO CYB5B (Homo sapiens) 6480464 Temozolomide results in decreased expression of CYB5B mRNA CTD PMID:31758290 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYB5B mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO Cyb5b (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYB5B mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYB5B mRNA] CTD PMID:31150632 tetracycline increases expression ISO Cyb5b (Mus musculus) 6480464 Tetracycline results in increased expression of CYB5B mRNA CTD PMID:16917069 thapsigargin decreases expression ISO CYB5B (Homo sapiens) 6480464 Thapsigargin results in decreased expression of CYB5B mRNA CTD PMID:22378314 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of CYB5B protein CTD PMID:35544339 trichostatin A decreases expression ISO CYB5B (Homo sapiens) 6480464 trichostatin A results in decreased expression of CYB5B mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO CYB5B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYB5B mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO Cyb5b (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CYB5B mRNA CTD PMID:19042947 tunicamycin decreases expression ISO CYB5B (Homo sapiens) 6480464 Tunicamycin results in decreased expression of CYB5B mRNA CTD PMID:22378314 valproic acid affects expression ISO Cyb5b (Mus musculus) 6480464 Valproic Acid affects the expression of CYB5B mRNA CTD PMID:17292431 valproic acid increases expression ISO CYB5B (Homo sapiens) 6480464 Valproic Acid results in increased expression of CYB5B mRNA CTD PMID:23179753 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYB5B mRNA CTD PMID:22570695 vorinostat increases expression ISO CYB5B (Homo sapiens) 6480464 vorinostat results in increased expression of CYB5B mRNA CTD PMID:27188386